The Beachbody Company to Participate in the Jefferies Virtual Fitness & Wellness Summit

EL SEGUNDO, Calif.–(BUSINESS WIRE)–The Beachbody Company, Inc. (NYSE: BODY) (“Beachbody” or the “Company”), a leading subscription health and wellness company, today announced that Beachbody’s Co-Founder, Chairman and Chief Executive Officer, Carl Daikeler, and Chief Financial Officer, Marc Suidan, will participate in a fireside chat at the Jefferies Virtual Fitness & Wellness Summit on Monday, September … [Read more…]

Equillium to Acquire Metacrine in All-Stock Transaction

Expected to add $33 million in cash at closing to Equillium’s balance sheet and extend operating runway into 2024 Acquisition includes novel drug candidate MET642, an orally delivered Phase 2 ready FXR agonist for ulcerative colitis Preston Klassen, M.D., MHS, to be appointed to the Board of Directors LA JOLLA, Calif.–(BUSINESS WIRE)–$EQ #GVHD–Equillium, Inc. (Nasdaq: … [Read more…]

Earlens Shares FDA Historical Ruling on OTC Hearing Aids

MENLO PARK , Calif.–(BUSINESS WIRE)–Earlens, a privately held medical technology company transforming the way people hear with a new class of non-surgical hearing technology, supports the FDA’s ruling to create a new category of Over the Counter (OTC) hearing aids. Hearing loss, a medical epidemic associated with dementia, depression and social isolation, affects an estimated … [Read more…]

Scheduling for COVID-19 Boosters Now Available at Rite Aid and Bartell Drugs Locations

Appointments can be made through the online schedulers at Riteaid.com and Bartelldrugs.com PHILADELPHIA–(BUSINESS WIRE)–Rite Aid (NYSE: RAD) today announced that scheduling is now available for the updated boosters of the mRNA Pfizer and Moderna COVID-19 vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest. “At Rite Aid, we recognize the important … [Read more…]

U.S. Mechanical Ventilator Market Trends/Analysis Report 2022: A $1.25 Billion Market by 2030 – Focus on Impacts of COVID-19 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “U.S. Mechanical Ventilator Market Size, Share & Trends Analysis Report by Product (Critical Care, Neonatal, Portable, Accessories, Flow Sensors, Breathing Circuits, Masks), by End-use and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. mechanical ventilator market size is expected to reach USD 1.25 billion by 2030. It is expected … [Read more…]

Global Exosome Market Report 2022: Rising Numbers of Clinical Trials Propelling Sector Forward – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The Global Exosome Market – Market Size, Forecast, Trials, and Trends, 2022” report has been added to ResearchAndMarkets.com’s offering. Exosome technologies have been developing rapidly in recent years and substantial growth is expected for the market as they get integrated into the fields of liquid biopsy, precision medicine, and regenerative medicine. In particular, … [Read more…]

United States Veterinary Oncology Market Trends/Analysis Report 2022: A $171.16 Million Market by 2030 – Use of Canines as a Model for Clinical Trials by Researchers Aiding Market Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “U.S. Veterinary Oncology Market Size, Share & Trends Analysis Report by Therapy (Surgery, Radiology, Chemotherapy, Immunotherapy), by Animal Type (Canine, Feline), and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. veterinary oncology market size is expected to reach USD 171.16 million by 2030 The market is expected to expand … [Read more…]

Real Time Medical Systems and Lightbeam Health Solutions Partner to Improve Care Transitions and Value-based Care Outcomes

Partnership will provide live data insights into post-acute markets to enable providers and payers to improve clinical, financial, and care outcomes spanning the entirety of the continuum of care BALTIMORE–(BUSINESS WIRE)–Real Time Medical Systems (Real Time), the industry-leading, KLAS-rated, and HITRUST Certified interventional analytics solution, today announced a strategic partnership with Lightbeam Health Solutions, to … [Read more…]

Sebastian Guth Named to PharmaVoice 100 List of Most Inspiring Leaders for 2022

WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer announced today that Sebastian Guth, president of Bayer Pharmaceuticals, Americas and member of the global Pharmaceutical Executive Committee, has been named to the PharmaVoice 100, an annual list of the most inspiring leaders in the life sciences industry, representing innovators; disrupters; and champions of diversity, equity and inclusion. A 20-year veteran of … [Read more…]

Fresenius Kabi Receives U.S. FDA Approval for Biosimilar Stimufend® (pegfilgrastim – fpgk)

Fresenius Kabi’s first approved U.S. biosimilar Provides accessible, high-quality treatment option for U.S. cancer patients undergoing chemotherapy to reduce the incidence of infection as manifested by febrile neutropenia Broadens the company’s global biosimilars portfolio focused on oncology and immunology Another key milestone in the company’s Vision 2026 growth strategy BAD HOMBURG, Germany–(BUSINESS WIRE)–#FreseniusKabi–Fresenius Kabi, a … [Read more…]